Manufacturer record

Prosperity Drugs Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Prosperity Drugs Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between March 2026 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: MFBL25006, XTPARA MF 100Suspension (exp May 2027). DTL Jabalpur Madhya Pradesh (state lab) found it not of standard quality: Suspension does not dispose uniformly on shaking - Description. Listed in the September 2026 alert.

Records by type

2 records linked to Prosperity Drugs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2026 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2026
2
Products affected
Dissolution
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
XTPARA MF 100Suspension Batch MFBL25006Mfg Jun 2025 · Exp May 2027 Suspension does not dispose uniformly on shaking - DescriptionDescription DTL Jabalpur Madhya PradeshState lab Sep 2026
Rabeprazole Sodium (Enteric-coated) and Domperidone (Sustained-release) Capsules Batch ARDC25051Mfg Aug 2025 · Exp Jul 2027 The sample does not conform to Manufacturer's Specification with respect to the test of Dissolution of Rabeprazole Sodium in buffer stage.Dissolution CDL, KolkataCDSCO lab Mar 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.